KRAS and infection: In mice, the whole attenuated YF-17D vaccine induces a CD8+ T cells response, which peaks at day 7 after infection and is specific for a dominant viral epitope present in the NS3 protein; this latter NS3-specific, CD8+ T cell response is not induced by the Ad-YF CME vaccine32.